A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial - Concepedia

Concepedia

Publication | Open Access

A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus–Associated Tuberculous Meningitis: The LASER-TBM Trial

DOI Full Paper Access

37

Citations

20

References

2022

Year

Angharad Davis, Sean Wasserman, Cari Stek, Mpumi Maxebengula, Chen Liang, Stephani Stegmann, Sonya Koekemoer, Amanda Jackson, Yakub Kadernani, Marise Bremer,

Clinical Infectious Diseases

Abstract

NCT03927313.

References

	Year	Citations

Page 1